• Homepage
  • Companies
  • Lobesity

Lobesity

Lobesity is developing a pharmaceutical agent to prevent obesity. The agent is initially targeting those patients with non-alcoholic fatty liver disease and hepatic steatosis.

News: Lobesity Investors Raise $1.80 million Financing

  • Website

Back To Companies
bioenterprise logo

About Us

We partner with people who have a passion for improving health and wellbeing. They are scientists, entrepreneurs, innovators and company founders with creativity and drive woven into their very DNA.

Menu

  • Legal
  • Contact

© 2019 All rights reserved.